In this study, we first applied a systems biology approach for analyzing single-cell RNA-seq data of MS patients and healthy controls that characterized the presence of CTLA-4 and PD-L1 in the different cell populations. This evidence concerns the gene CTLA4 and myeloid sarcoma.